rjs - Thank you (and Buildit) for your posts. I suspect

New Post Public Reply Private Reply Replies (0) Message Board
FanMail rjs9787 #35159
654
rjs -
Thank you (and Buildit) for your posts. I suspect [strongly] that some on here believe that my motives have been negative only when it came to the success of GNBT and NuGen, and from reading the posts (especially out of context), I can see that being the impression. To give them a little context, however, it was about a year ago that I first started posting on IH, and my initial issue was the "unsanctioned" trading of NUGX on OTC, when we were told that NuGen was going to be listed on NASDAQ, and under the symbol NGIO (the symbol had been reserved the previous September, I believe). No one, including MMPJOE, however, could/would give me any information whatsoever on how NUGX started trading, and who was behind it, despite the fact that filings had to be made in order to trade, not only filed by someone named in the filing, but also containing information that seemed to me to be not readily available. The other unusual circumstance was that it was only the first tranche of the dividend shares that could be traded as NUGX on the OTX, and not the second tranche. I never could obtain an answer from anyone (again including MMPJOE) as to what that would be, and again, information that would be readily known to or ascertainable by, the CEO/Pres/CoB (and perhaps others). This was the issue that first triggered some real suspicion about what was going on with the company, and it likewise is not the kind of issue that management would be proper in telling me (either implicitly or in so many words) that it was "none of my business," as I was (and still am) a shareholder of NUGX shares.

The next issue that arose was the Last Chance for Children fundraising efforts. When I started looking more than superficially at the organization (I'll be kind, and call it that at this point), it turned out that, LCFC was organized for the purpose of curing Type 1 diabetes i children, not providing a COVID vaccine. It was readily available on guidestar.org, that rates charitable organizations. Lo and behold on the website for LCFC itself, however, was no reference at all to DM, or any cure for children. Another red flag. Once again, my posts on this issue were not well-received.

Then came the May CC, and the hoopla surrounding the AZ facility opening. In fact, that facility was supposed to have been finished, and up-and-running. There was no extrinsic (i.e., independent) evidence of that being the case, however, from any source outside GNBT. Again, no one would answer why that would be the case. Unbeknownst to me, however, time was running out to get answers, because other than a brief PR in July, the companies would "go dark" following that CC.

Along the way, and before my participation in IH, there were other events and circumstances that began to lead me to question the prudence of my investment, but like many others (still some on here, I expect), I chose to believe that these were just bumps in the proverbial road of small biotechs, and that everything eventually would get sorted, especially with someone at the helm who appeared to demonstrate a true dedication to both the investors as well as the goals of the companies. As we know now, of course, it was a matter of "all sizzle, no steak" sold to us by a clever person who appealed both to our vanity ("loyal shareholders" and our own desire to be a part of something that would benefit many others.

So now, like hylander and others, I am infuriated by the cowardice exhibited by the CEO/Pres/CoB, who will not step forward and tell us what happened. And did you ever notice that Joe never personally told anyone that he or GNBT was subject to an actual gag order? That was the inference some drew, and who was he to kill that rumor? If he actually had announced that there was such an order, then anyone could go to the source to confirm it, and if it were not true, that in itself would be defrauding investors. And before anyone is inspired to respond by saying "maybe Joe can't tell anyone that he is not allowed to tell anyone," think about just how foolish that remark would be in the context of a fiduciary's legal obligations.

I agree with NYD and others that there are bad tidings coming, because bad things have been happening. When lawyers tell clients not to talk to anyone, it is for a reason; usually, it is for multiple reasons. I am not looking for a "pound of flesh" from the CEO, but I am looking forward to the exposure of the truth.

Oh, and before I forget -

quack, quack, paddle, paddle, waddle, waddle.

Have a safe and relaxing weekend, and pray for those affected by the Ukraine invasion.

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Investors, Portillo's Fraud Claims Demand Your Attention

Updated Category News Views 30

Portillo's Investors Caught in a Tough Spot Ah, Portillo's. You thought those hot dogs were the only spicy thing you're biting into? Try these allegations on for size. Investors are biting back with a securities fraud lawsuit, and the details are saltier than a bucket of fries. The folks who held PTLO shares between September 19, 2023, and May 4, 2026, are in the...

Continue Reading
Disney+ Teams Up with Tiff's: Blue Cookie Debut

Updated Category News Views 69

A Sweet Collaboration on the Horizon If somebody had told me that cookies could conjure up excitement equivalent to a TV show's new season, I'd have laughed. But here we are—Disney+ and Tiff's Treats are cooking up a storm with blue chocolate chip cookies to celebrate 'Percy Jackson and the Olympians' Season 3 premiere. The Cookie That Packs a Punch Forget ordinary...

Continue Reading
A&G Management's Bold New Era with WPM Partnership

Updated Category News Views 122

Shaking Up Baltimore's Real Estate Scene Swapping up management partners can be a dicey game, but A&G Management seems to be pulling it off without a hitch. As of January 4, 2027, WPM Real Estate Management will take over the reins for more than 3,000 apartment homes scattered across Anne Arundel, Howard, and Baltimore counties. A new set of hands is stepping in for...

Continue Reading
Duolingo Faces Class Action: Key Investor Steps

Updated Category News Views 110

Navigating Turbulent Times with Duolingo Holy moly, the dumpster fire that is the Duolingo (NASDAQ:DUOL) legal saga just got hotter. If you snagged yourself some shares between May 2, 2025, and February 26, 2026, you'd better sit down and grab some antacids—because the nauseating roller coaster is far from over. Robbins LLP is rounding up the troops for a class action,...

Continue Reading
DEFSEC Completes 9-to-1 Share Consolidation

Updated Category News Views 79

DEFSEC Technologies Tightens the Belt So, DEFSEC Technologies just pulled off something that'll kick up dust among investors. A 9-to-1 share consolidation—now that's no small fry. For those riding the NASDAQ or the TSX Venture with a tight grip on their DEFSEC shares, it's strictly business today. Post-consolidation, DEFSEC's common shares are set to trade under the...

Continue Reading
IP Lawyer Chris Henry Returns to Latham: A Game Changer

Updated Category News Views 106

Welcome Home, Chris Henry! Folks, here's a headline that's making waves in the IP litigation water: Chris Henry has returned to Latham & Watkins, taking his place as a heavyweight partner in their Boston office. Now, if you're not deeply entangled in the world of high-stakes intellectual property (IP) disputes, you might shrug. But for tech companies embroiled in patent...

Continue Reading
BETR's Legal Tangle: A Deeper Dive into Investor Turmoil

Updated Category News Views 52

BETR's Shaky Ground: When Promises Fall Short In the rough-and-tumble world of finance, there's little room for empty promises. Better Home & Finance Holding Company (NASDAQ: BETR) might have to learn that the hard way. Investors who snagged shares between March 13 and August 6, 2026, are now clutching their heads as they watch their investments nosedive. When companies...

Continue Reading
Portillo's Faces Legal Heat: Investor Class Action Filed

Updated Category News Views 101

What’s Eating Portillo's? Ah, once upon a misstep in the land of promising expansion, now we have Portillo's Inc. (NASDAQ: PTLO) neck-deep in legal hot water. Those golden fries and famous sandwiches somehow didn't pave the way for stockholder bliss. Why the turmoil? On an ordinary November morning, the DJS Law Group made it clear: They're rallying the troops for a...

Continue Reading
Painter's Accessory Aims to Revolutionize Convenience

Updated Category News Views 64

Crafty New Invention Targets Painters' Ease Ever find yourself tangled in paintbrushes and rollers while trying to get that perfect coat on the wall? Well, a painter from Bracebridge, Ontario, has had it with the struggle and is looking to stir the pot with their latest invention, the NU LIFE LINER. It's sleek, it's practical, and it's aimed at flipping the painting game...

Continue Reading
Palatin's Game-Changer: MC4R Agonist Hits the Stage

Updated Category News Views 83

Breaking New Ground in Obesity Treatment Palatin Technologies is stepping into the spotlight with some heavy ammunition in the fight against obesity. The company has just unveiled impressive preclinical data about their next-generation melanocortin-4 receptor (MC4R) agonists at the ObesityWeek® 2026 conference. This isn’t just your run-of-the-mill corporate...

Continue Reading

Top 5 Most Recently Viewed Articles

ROHM's AI-Driven Microcontrollers Revolutionize Machine Efficiency

Updated Category News Views 265

Introduction to ROHM's Innovative AI MCUs In a groundbreaking announcement, ROHM Semiconductor has unveiled a new line of microcontrollers (MCUs) equipped with advanced artificial intelligence capabilities. These AI-enabled MCUs are designed to optimize machine performance and proactively predict equipment failures by analyzing real-time data. ROHM's new technology...

Continue Reading
Nvidia Clarifies Investment Strategy Amid Market Uncertainty

Updated Category News Views 237

Nvidia Stock Reacts to New Clarifications on Investment NVIDIA Corporation (NASDAQ: NVDA) experienced a slight dip in premarket trading as investors responded to CEO Jensen Huang's recent statements about the company's potential engagement with OpenAI. Huang, addressing reporters in Taipei, clarified that the previously mentioned $100 billion was not a binding commitment...

Continue Reading
CPTx Strengthens Leadership with New CFO Appointment

Updated Category News Views 223

CPTx Welcomes McDavid Stilwell as Chief Financial Officer In a significant move to bolster its strategic and financial expertise, CPTx GmbH has appointed McDavid Stilwell as its new Chief Financial Officer (CFO). With a wealth of experience in finance and corporate strategy, Mr. Stilwell's leadership is expected to play a crucial role as the company works towards...

Continue Reading
Jupiter Neurosciences Celebrates Key Milestones in Growth Journey

Updated Category News Views 163

Jupiter Neurosciences Celebrates Key Milestones in Growth Journey Company advances JOTROL into Phase 2a Parkinson’s trial, launches Nugevia consumer brand, and strengthens financial position As Jupiter Neurosciences embarks on the journey into 2026, its first full year as a public company marks a pivotal moment. The company, known for its development of JOTROL, a...

Continue Reading
Challenges Ahead: Indian Corporate Earnings Growth Slows

Updated Category News Views 143

Indian Corporate Earnings Growth Faces Slowdown Recent insights from analysts reveal that Indian corporate earnings growth is expected to reach a three-year low. The slowdown is primarily attributed to weak performance across various sectors, as indicated in a note by Morgan Stanley. The once persistent upcycle of double-digit earnings growth appears to be stalling,...

Continue Reading